Created date

Published on

You are here:

MS in the media - 21 July 2017

15 - 21 July 2017

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Access to disease modifying drugs

Missing Pieces, a survey of MS health professionals (HPs) and people with MS by pharmaceutical company Sanofi, found that three quarters of HPs thought people with relapsing MS are facing delays in starting treatment with a disease modifying drug. The proportion of people on a drug is lower than most European countries. The lack of MS neurologists and facilities are listed as the main reasons for the delay.

Source: Sanofi press release
Source: Guardian

MS Trust link: MS Decisions - a guide to the disease modifying drugs

 

The cost of MS

European research shows that the cost of MS increases as MS becomes more severe - from €22,800/year for mild MS (EDSS 3 or lower) to €57,500 for severe MS (EDSS 7 or above). Quality of life and work capacity also dropped off sharply.

Source: MS News Today

MS Trust link: MS research updates

Protecting cognitive reserve

Research suggests nine lifestyle changes to reduce dementia related brain tissue loss and build up reserves that help the brain compensate for problems. Although the causes are quite different, these brain health factors also apply to protecting against build-up of cognition symptoms in MS

Source: BBC
Source: MedPage Today

MS Trust link: Brain health

Diet and childhood MS

US research studied the diets of people aged between 3 and 22 but were unable to find any foods associated with developing MS.

Source: MS Australia

MS Trust link: Diet

Vitamin D and bone health

A small Norwegian study found that people with MS taking a weekly 20,000 IU vitamin D supplement over two years showed no differences to bone mass density than a placebo group (though the results were compromised by half the people in the placebo group taking vitamin D supplement outside the study)

Source: Medical News Bulletin

MS Trust link: Vitamin D

Depression risk factors

Canadian research followed people with MS for six months and found that fatigue, limited mobility, low self-esteem and poor coping skills were associated with episodes of depression. More men than women reported depression.

Source: MS News Today

MS Trust link: Depression